Funding Opportunities

Join our charge in finding new solutions to vexing health care issues to help create a Minnesota-wide impact that moves knowledge to patients, and advances interprofessional education and clinical care.

Open

Masonic Cancer Center Clinical and Translational Research Support

Deadline: 12/31/2025
Support for novel research ideas that focus on a cancer research question.

Minnesota Partnership for Biotechnology and Medical Genomics

Deadline: LOIs due 7/11/23; Applications due 9/26/23
To position Minnesota as a world leader in biotechnology and medical genomics applications that will result in important new medical…

Office of Discovery and Translation Funding

Deadline: Accepting proposals on a continuous basis
Funding and expert guidance to develop solutions such as devices, diagnostics, therapeutics, software, and service models.

Closed

Karen Wyckoff Rein Sarcoma Foundation Research Grant

Deadline: To be announced
The research grants support one of the three major goals of the foundation; research patient and survivor support and education.

Pre-R01 Brainstorm

Deadline: To be announced
Funding to foster interdisciplinary collaborations encompassing novel, hypothesis-driven studies of cancer.

American Cancer Society Institutional Research Grant

Deadline: Deadline: To be announced
Support for promising new cancer-related research projects by junior faculty.

BOLD Ideas Grant

Deadline: To be announced
Interdisciplinary collaborations to tackle the complex issues affecting community and individual health.

Cancer Research Translational Initiative Exceptional Translational Research Award

Deadline: To be Announced
Outstanding translational research projects that lead to sustainable high impact external funding.

Child Health Collaborative Grant

Deadline: To be Announced
Funds to support child health research partnerships that improve health outcomes for Minnesota children and adolescents.

Clinical Trial Award Program: Regenerative Medicine Minnesota

Deadline: March 10, 2023
Supports the completion of a clinical trial for a regenerative medicine-based therapy (stem cell-based or genetic therapy) that addresses…